ALISO VIEJO, Calif., March 19, 2025 /PRNewswire/ — Terumo Neuro, a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corporation, proudly marks the 15th anniversary of ...
MinnPost’s reporters work hard to bring you news about what’s happening in MN. Your tax-deductible donation today will show your support of our journalists and keep our stories paywall-free. Five ...
Terumo Corporation’s (TRUMY) wholly-owned subsidiary MicroVention, Inc. recently announced the publication of the Clinical Evaluation of WEB 17 Device in Intracranial Aneurysms (CLEVER) study results.
SAN DIEGO & ALISO VIEJO, Calif.--(BUSINESS WIRE)--MicroVention, Inc., a global neurovascular company and wholly owned subsidiary of Terumo Corporation, announced the publication of WEB-IT 5-year ...
For the new study, Dr. Adeeb and colleagues compared the WEB device in bifurcation and sidewall aneurysms using a large database spanning more than 10 years from the WorldWideWEB consortium, a group ...
Hosted on MSN
Cleveland Clinic Abu Dhabi first in region to use new device for safer brain aneurysm treatment
Cleveland Clinic Abu Dhabi has become the first hospital in the Middle East and North Africa (MENA) region to deploy the Artisse Intrasaccular Flow Modulator, a cutting-edge device for treating ...
In an international study of patients with brain aneurysms (balloon-like bulges in weakened blood vessels), the Woven Endobridge device had a favorable efficacy and safety profile. A recent ...
The WEB device has proven clinical data, supported by seven global Good Clinical Practice (GCP) studies 2-8 and over 200 peer-reviewed publications. Over the past 15 years, this revolutionary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback